Related Experiment Video
Updated: Jun 18, 2026

Gene Regulation and Targeted Therapy in Gastric Cancer Peritoneal Metastasis: Radiological Findings from Dual Energy CT and PET/CT
Published on: January 22, 2018
The research progress of gastric cancer vaccines: a narrative review
Haoran Wu1,2, Fan Zhang1,2, Qiangzu Shao1,2
1Department of Surgical Oncology, The Second Hospital & Clinical Medical School, Lanzhou University, Lanzhou, China.
Background And Objective:
Gastric cancer (GC) vaccines are an important component of immunotherapy for GC. In recent years, continued advances in immunotherapy have driven substantial progress in vaccine development. This review summarizes and critically appraises recent developments in GC vaccine research, aiming to provide insights that may inform future vaccine design and development.
Methods:
A detailed narrative review of the recent literature was conducted to summarize the latest research progress on GC vaccines. The PubMed database was searched, with the most recent search completed on 31 December 2025.
Key Content And Findings:
This review summarizes recent advances in GC vaccine research. We briefly classify and describe current vaccine platforms, with a particular focus on emerging nucleic acid vaccines and nanovaccines and on strategies to enhance their efficacy. We also discuss approaches to overcoming the immunosuppressive tumor microenvironment (TME), optimizing the vaccine development pipeline, and evaluating artificial intelligence (AI)-based epitope prediction tools.
Conclusions:
Substantial opportunities remain to optimize the research and development of GC vaccines. With continued advances in immunology, molecular biology, and AI, together with large-scale population validation and cost-effective manufacturing, personalized vaccines and rational combination strategies are expected to accelerate the clinical translation of GC immunoprophylaxis and therapy, ultimately improving patient outcomes.
Related Concept Videos
Cancer Vaccines
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
Gastritis II: Pathophysiology
Targeted Cancer Therapies
There are several types of targeted therapies against specific...
Cancer Therapies
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
Cancer
Tumor Immunotherapy